Skip to main content

Dr. Brahmbhatt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Brahmbhatt's full profile

Already have an account?

Summary

  • Dr. Mihir Brahmbhatt is a gastroenterologist in Philadelphia, PA and is affiliated with multiple hospitals in the area. He received his medical degree from University of Missouri-Kansas City School of Medicine and has been in practice 8 years. He has more than 10 publications and 30 citings.

Education & Training

  • University of Missouri-Columbia
    University of Missouri-ColumbiaResidency, Internal Medicine, 2015 - 2018
  • University of Missouri-Kansas City
    University of Missouri-Kansas CityBachelor, 2009 - 2015
  • University of Missouri Kansas City School of Medicine
    University of Missouri Kansas City School of MedicineClass of 2015

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2023 - 2025
  • FL State Medical License
    FL State Medical License 2021 - 2023
  • PA State Medical License
    PA State Medical License 2018 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

Journal Articles

  • Liver transplantation for hepatic epithelioid hemangioendothelioma is facilitated by exception points with acceptable long-term outcomes  
    Mihir Brahmbhatt, Stacey Prenner, Therese Bittermann, Transplantation, 11/15/2019
  • A Multimodal Intervention Reduces Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Disease: 639  
    Rahul S Dalal, Sonali Palchaudhuri, Christopher Snider, Yevgeniy Gitelman, Mihir Brahmbhatt, Nikhil Mull, Shivan Mehta, Christopher Klock, James Lewis, Gary R Lichtens..., American Journal of Gastroenterology, 10/1/2019
  • Exogenous Insulin Therapy Increases the Risk of Advanced Colorectal Adenoma Among Patients With Type 2 Diabetes Mellitus: 244  
    Robert Lam, Sumanth Chennareddy, Mihir Brahmbhatt, Caroline Glassman, Yu-Xiao Yang, American Journal of Gastroenterology, 10/1/2019
  • Join now to see all

Abstracts/Posters

  • Evaluation of the reporting process of the tests pending at discharge in a community hospital.
    Foxworth J., Kisra S., Brahmbhatt M., Narsingham S., Journal of Academic Hospital Medicine; ACP Missouri

Lectures

  • Supervision of Alcoholism and Hand Sanitizer Consumption. 
  • Reducing False Positive Blood Cultures. 

Hospital Affiliations